Frazier Healthcare raises $377M venture fund, surpassing target

Frazier Healthcare has raised a $377 million fund, one of the largest in recent years by a Seattle venture firm. The firm, whose portfolio includes Achaogen, Atterocor, Portola Pharmaceuticals and other firms, had targeted $300 million. “We are very appreciative of the support that we received from existing limited partners and pleased to have brought in… Read More


Frazier Healthcare files to raise a $400 million venture fund

Frazier Healthcare, a  21-year-old venture capital firm with offices in Seattle and Silicon Valley, has filed documents with the Securities and Exchange Commission to raise up to $400 million for its seventh venture fund. The firm was founded by former Immunex Chief Financial Officer Alan Frazier, and now includes general partners James Topper, Patrick Herron,… Read More